For broader guidance on beginning a peptide-based protocol, see getting started with peptides
Collagen peptides operate through entirely different mechanisms than retatrutide and do not interact with GLP-1, GIP, or glucagon receptors
The retatrutide dosing protocols are still being refined through clinical trials
The most common side effects are digestive: nausea, vomiting, diarrhea, and constipation, especially when starting or raising the dose
Preventing beta cell de-differentiation, stimulating proliferation and differentiation of pluripotent stem cells, and enhancing CRISPR-targeted gene editing can be mediated with small molecules and used in conjunction with conventional glucose-lowering therapies
Allow us to answer the most frequently asked ones